3

PRIMARY DOCUMENT

Company: ELITE PHARMACEUTICALS INC /NV/
Filed: February 23, 2011
Period of Report: February 23, 2011
Accession Number: 0001126562-11-000002

View Document ↗ View on SEC.gov ↗